Table of Contents

1 Anidulafungin Market Overview

• 1.1 Product Overview and Scope of Anidulafungin
• 1.2 Classification of Anidulafungin by Types
  • 1.2.1 Global Anidulafungin Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Anidulafungin Revenue Market Share by Types in 2018
  • 1.2.3 50 mg per vial
  • 1.2.4 100 mg per vial
• 1.3 Global Anidulafungin Market by Application
  • 1.3.1 Global Anidulafungin Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Drug store
• 1.4 Global Anidulafungin Market by Regions
  • 1.4.1 Global Anidulafungin Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Anidulafungin Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Anidulafungin Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anidulafungin Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Anidulafungin Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anidulafungin Status and Prospect (2014-2024)
• 1.5 Global Market Size of Anidulafungin (2014-2024)

2 Manufacturers Profiles

• 2.1 Pfizer
  • 2.1.1 Business Overview
  • 2.1.2 Anidulafungin Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Pfizer Anidulafungin Revenue, Gross Margin and Market Share (2017-2018)

3 Global Anidulafungin Market Competition, by Players

• 3.1 Global Anidulafungin Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Anidulafungin Players Market Share
  • 3.2.2 Top 10 Anidulafungin Players Market Share
• 3.3 Market Competition Trend

4 Global Anidulafungin Market Size by Regions

• 4.1 Global Anidulafungin Revenue and Market Share by Regions
• 4.2 North America Anidulafungin Revenue and Growth Rate (2014-2019)
• 4.3 Europe Anidulafungin Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Anidulafungin Revenue and Growth Rate (2014-2019)
• 4.5 South America Anidulafungin Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Anidulafungin Revenue and Growth Rate (2014-2019)

5 North America Anidulafungin Revenue by Countries

• 5.1 North America Anidulafungin Revenue by Countries (2014-2019)
• 5.2 USA Anidulafungin Revenue and Growth Rate (2014-2019)
• 5.3 Canada Anidulafungin Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Anidulafungin Revenue and Growth Rate (2014-2019)

6 Europe Anidulafungin Revenue by Countries

• 6.1 Europe Anidulafungin Revenue by Countries (2014-2019)
• 6.2 Germany Anidulafungin Revenue and Growth Rate (2014-2019)
• 6.3 UK Anidulafungin Revenue and Growth Rate (2014-2019)
• 6.4 France Anidulafungin Revenue and Growth Rate (2014-2019)
• 6.5 Russia Anidulafungin Revenue and Growth Rate (2014-2019)
• 6.6 Italy Anidulafungin Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Anidulafungin Revenue by Countries

• 7.1 Asia-Pacific Anidulafungin Revenue by Countries (2014-2019)
• 7.2 China Anidulafungin Revenue and Growth Rate (2014-2019)
• 7.3 Japan Anidulafungin Revenue and Growth Rate (2014-2019)
• 7.4 Korea Anidulafungin Revenue and Growth Rate (2014-2019)
• 7.5 India Anidulafungin Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Anidulafungin Revenue and Growth Rate (2014-2019)

8 South America Anidulafungin Revenue by Countries

• 8.1 South America Anidulafungin Revenue by Countries (2014-2019)
• 8.2 Brazil Anidulafungin Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Anidulafungin Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Anidulafungin Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Anidulafungin by Countries

• 9.1 Middle East and Africa Anidulafungin Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Anidulafungin Revenue and Growth Rate (2014-2019)
• 9.3 UAE Anidulafungin Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Anidulafungin Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Anidulafungin Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Anidulafungin Revenue and Growth Rate (2014-2019)

10 Global Anidulafungin Market Segment by Type

• 10.1 Global Anidulafungin Revenue and Market Share by Type (2014-2019)
• 10.2 Global Anidulafungin Market Forecast by Type (2019-2024)
• 10.3 50 mg per vial Revenue Growth Rate (2014-2024)
• 10.4 100 mg per vial Revenue Growth Rate (2014-2024)

11 Global Anidulafungin Market Segment by Application

• 11.1 Global Anidulafungin Revenue Market Share by Application (2014-2019)
• 11.2 Anidulafungin Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Drug store Revenue Growth (2014-2019)

12 Global Anidulafungin Market Size Forecast (2019-2024)

• 12.1 Global Anidulafungin Market Size Forecast (2019-2024)
• 12.2 Global Anidulafungin Market Forecast by Regions (2019-2024)
• 12.3 North America Anidulafungin Revenue Market Forecast (2019-2024)
• 12.4 Europe Anidulafungin Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Anidulafungin Revenue Market Forecast (2019-2024)
• 12.6 South America Anidulafungin Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Anidulafungin Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology

Anidulafungin (INN) (trade names Eraxis, Ecalta) is a semisynthetic echinocandin used as an antifungal drug. It was previously known as LY303366. It may also have application in treating invasive Aspergillus infection.

Scope of the Report:
The global Anidulafungin market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Anidulafungin.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Anidulafungin market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Anidulafungin market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
50 mg per vial
100 mg per vial

Market Segment by Applications, can be divided into
Hospital
Drug store